Endometrial Cancer Trial, Recruiting NCT07345897 Sponsor: University of Rochester Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT07345897
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Cisgender women, or transgender or non-binary people who have a cervix
  • People aged between 30 and 65 years old
  • People who are able to understand the trial and make their own decision about taking part

Who may not be able to join:

  • People who have had a hysterectomy where the cervix was also removed
  • People who have a known HIV diagnosis (as cervical screening guidelines for people with HIV follow different recommendations)
  • People who are not able to give their own consent — for example, due to reduced decision-making capacity, intoxication, or being in distress at the time
  • People who are currently pregnant, or who have given birth within the past three months
  • People who have used vaginal products in the past 3 days, such as suppositories, creams, washes, vaginal contraceptives, or condoms
  • People who have had sexual intercourse, a transvaginal ultrasound, or a gynaecological examination within the past 2 days

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 585-274-1509

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
13 February 2026
Est. completion
1 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Uptake of cervical cancer screening from self-sampling in the ED

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov